An effort two decades in the making, Vertex Pharmaceuticals Inc.’s suzetrigine gained U.S. FDA approval as the first drug targeting the NaV1.8 pain signal. Branded Journavx, the oral small molecule is ...

NEW YORK – The UK National Institute for Health and Care Excellence on Friday issued a final draft guidance recommending that the National Health Service (NHS) make Vertex Pharmaceuticals and CRISPR ...

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. By Gina Kolata The Food and Drug Administration approved a new medication Thursday to treat ...

Vertex has built an empire in cystic fibrosis (CF) treatment, recently crowning its dominance with Alyftrek's approval last month. This latest CF drug adds even more firepower to a franchise ...

The bottom line is few companies can match its combination of established leadership in rare diseases and realistic pathways to significant market expansion, making Vertex stock a worthwhile buy ...

HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...

Angel, a restaurant server who originally hails from Iowa, was more familiar with cold-weather recreation than his companions, though his snowman-making skills were questionable. He’d led in the ...

“I didn’t realise that was for if you wanted a cappuccino,” she said, revealing she was instead trying to make a different drink. But many social media users revealed that they also had no ...